In, size of the Global Head and Neck Cancer Diagnostics Market was valued nearly USD 500 million. The global head and neck cancer diagnostics market is projected to grow with a CAGR between 13% and 14% during 2016-2022 and reach USD 1.xx billion by 2022. Increasing geriatric patient population especially patients suffering from head and neck cancer, advancement in treatment modes, and advanced diagnostic technologies are considered as the prime factors driving the growth of this market. Moreover, unfavorable government regulations regarding new researches, high cost associated with the treatment modes and lack of awareness among the people about the head and neck cancer are the key restraining factors in this market. Furthermore, rise in the chronic diseases among aging population, rise in the healthcare expenditure of people, and better healthcare initiatives from Government and private organizations are anticipated to create more opportunities for the growth of this market during the forecast period. Nevertheless, low adoption rate of digital technology based systems and untapped markets are considered to be the challenges faced by the global head and neck cancer diagnostics market.

Segments Covered:

The global head and neck cancer diagnostics market based on diagnostic methods is segmented into diagnostic imaging, endoscopy screening, bioscopy screening, blood test and dental diagnostic and others.

Geographic Coverage and Analysis:

The report provides regional analysis covering geographies such as North America, Europe, Asia Pacific, Latin America and Rest of the World (RoW). North America is accounted for the largest market share region in the global head and neck cancer diagnostic market owing more than 47% share. Rising aging population with chronic disease, with head and neck cancer related and highly developed healthcare infrastructure are considered to be the key factors for the growth of this market region. Moreover, Asia pacific is expected to be the most prominent and faster growing market due to presence of emerging economies such as India, China, and Indonesia. Asia Pacific is anticipated to grow at the highest CAGR rate over the forecast period and provides more opportunities due to increasing demand for developed healthcare infrastructure, rising expenditure of patient population and rising cases of head and neck cancer in the region.

Companies Profiled:

The companies covered in the report include

Siemens Healthcare
GE Healthcare
Philips Healthcare
AdDent Inc.
Varian Medical Systems
Fujifilm Holdings
Hitachi Medical
LED Medical Diagnostics
Shimadzu Corp.
ASAHI Roentgen
Karl Storz